TABLE 2.
Information about EXP and the repeated measures.
| Patients with cLBP | Pain-free volunteers | Statistics for group | |
| Mean (SD) | Mean (SD) | comparison | |
| Sample size | n = 10 (n = 9 for FU-EXP) | n = 10 | n.a. |
| Age (years) | 40.2 (11.3) | 39.6 (12.2) | F(1,18) = 0.01, p = 0.91 |
| Sex | 9 males 1 female |
8 males 2 females |
X2(1, n = 20) = 0.39, p = 0.53 |
| Pain duration | 6–12 months: n = 1 1–2 years: n = 2 2–5 years: n = 5 >5 years: n = 2 |
n.a. | n.a. |
| EXP treatment duration (days) | 45.0 (15.9) | n.a. | n.a. |
| Time between pre-EXP session and start EXP treatment (days) | 29.3 (12.2) | n.a. | n.a. |
| Time between pre-EXP and post-EXP session (days) | 96.1 (42.1) | 92.3 (33.5) | F(1,18) = 0.05, p = 0.83 |
| Time between post-EXP and FU-EXP session (days) | 186.4 (9.6) | n.a. | n.a. |
n.a., not applicable.